Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction

Abstract: The utility of a midcycle bone marrow biopsy (BMB) for early assessment of response in patients with acute myeloid leukemia (AML) after intensive chemotherapy (IC) induction is contested. Even when challenged, there is little consideration as to the possibility of different response dynami...

詳細記述

書誌詳細

出版年:	Blood Advances
主要な著者:	Meira Yisraeli Salman, Alexander R. Terry, Andriy Derkach, David Nemirovsky, Kuo-Kai Chin, Yannis K. Valtis, Leora Boussi, Theresa Spivey, Wenbin Xiao, Christopher Famulare, Jenna Ciervo, Jacob M. Rowe, Martin S. Tallman, Eytan M. Stein
フォーマット:	論文
言語:	英語
出版事項:	Elsevier 2025-07-01
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2473952925002071